Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 23220014)

Published in Biol Blood Marrow Transplant on December 07, 2012

Authors

Nancy Robitaille1, Jacques Lacroix, Lubomir Alexandrov, Lucy Clayton, Marion Cortier, Kirk R Schultz, Henrique Bittencourt, Michel Duval

Author Affiliations

1: Service d'Hématologie-Oncologie, Centre de Cancérologie Charles-Bruneau, Département de Pédiatrie, CHU Sainte-Justine, Université de Montréal, 3175 chemin de la Côte-Sainte-Catherine,Montréal, Quebec, Canada.

Articles by these authors

Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis (2004) 6.65

Hypothermia therapy after traumatic brain injury in children. N Engl J Med (2008) 6.10

Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet (2003) 5.40

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood (2004) 3.61

One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med (2014) 3.07

Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med (2007) 2.60

Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med (2004) 2.56

Age of transfused blood in critically ill adults. N Engl J Med (2015) 2.52

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood (2007) 2.36

Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med (2011) 2.35

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol (2010) 2.31

Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood (2011) 2.29

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant (2006) 2.24

Parental involvement in treatment decisions regarding their critically ill child: a comparative study of France and Quebec. Pediatr Crit Care Med (2007) 2.22

The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York. Genet Med (2009) 2.07

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood (2013) 1.84

Modes of death in pediatrics: differences in the ethical approach in neonatal and pediatric patients. J Pediatr (2013) 1.81

Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med (2008) 1.80

Targeted temperature management in critical care: a report and recommendations from five professional societies. Crit Care Med (2011) 1.72

Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum. Pediatr Crit Care Med (2011) 1.64

Ventilator-associated pneumonia in intubated children: comparison of different diagnostic methods. Pediatr Crit Care Med (2003) 1.62

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant (2006) 1.58

Evaluation of the pediatric risk of admission score in a pediatric emergency department. Ann Emerg Med (2003) 1.58

Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study. Crit Care Med (2005) 1.57

Survey on transfusion practices of pediatric intensivists. Pediatr Crit Care Med (2002) 1.55

Impact of Sim1 gene dosage on the development of the paraventricular and supraoptic nuclei of the hypothalamus. Eur J Neurosci (2009) 1.54

Clinical equipoise regarding glycemic control: a survey of pediatric intensivist perceptions. Pediatr Crit Care Med (2013) 1.52

Children with chronic conditions in pediatric intensive care units located in predominantly French-speaking regions: Prevalence and implications on rehabilitation care need and utilization. Crit Care Med (2009) 1.52

Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome. Haematologica (2005) 1.50

Respiratory Dysfunction Associated With RBC Transfusion in Critically Ill Children: A Prospective Cohort Study. Pediatr Crit Care Med (2015) 1.46

Paediatric logistic organ dysfunction (PELOD) score. Lancet (2006) 1.45

Clinical Outcomes Associated With RBC Transfusions in Critically Ill Children: A 1-Year Prospective Study. Pediatr Crit Care Med (2015) 1.44

Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy. Pediatr Crit Care Med (2010) 1.42

Survey on stated transfusion practices in PICUs*. Pediatr Crit Care Med (2014) 1.42

PICU mortality: is it better 9 to 5? Pediatr Crit Care Med (2005) 1.42

Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood (2002) 1.41

CD8(+) T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse. Blood (2011) 1.40

Is routine chest radiography necessary for the initial evaluation of fever in neutropenic children with cancer? Pediatr Blood Cancer (2004) 1.40

Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood (2007) 1.36

A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer (2008) 1.35

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33

Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med (2008) 1.25

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol (2008) 1.25

Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients. Transfusion (2010) 1.25

The pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med (2009) 1.24

Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood (2009) 1.23

Association between length of storage of red blood cell units and outcome of critically ill children: a prospective observational study. Crit Care (2010) 1.23

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood (2009) 1.22

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant (2012) 1.21

Hypothermia therapy after pediatric cardiac arrest. Circulation (2009) 1.19

Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.16

PELOD-2: an update of the PEdiatric logistic organ dysfunction score. Crit Care Med (2013) 1.16

Inspiratory muscle unloading by neurally adjusted ventilatory assist during maximal inspiratory efforts in healthy subjects. Chest (2007) 1.15

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. Blood (2014) 1.14

Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion (2010) 1.14

Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer (2006) 1.13

Complications of apheresis in children. Transfusion (2007) 1.10

Prolonged neural expiratory time induced by mechanical ventilation in infants. Pediatr Res (2004) 1.10

Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ (2007) 1.08

Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant (2005) 1.08

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol (2005) 1.08

Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res (2005) 1.08

Daily estimation of the severity of multiple organ dysfunction syndrome in critically ill children. CMAJ (2010) 1.07

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol (2002) 1.06

Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med (2010) 1.05

Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report. Biol Blood Marrow Transplant (2007) 1.05

Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion (2006) 1.04

Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica (2010) 1.02

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant (2012) 1.00

CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology (2012) 1.00

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides. Blood (2006) 1.00

Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol Blood Marrow Transplant (2008) 0.99

LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency. J Med Genet (2011) 0.98

In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2). Bioorg Med Chem (2007) 0.98

Length of cord blood unit cryopreservation does not impact hematopoietic engraftment. Transfusion (2008) 0.98

Randomized clinical trials in pediatric critical care: Rarely done but desperately needed. Pediatr Crit Care Med (2002) 0.97

Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics (2009) 0.97

Acute transfusion reactions in the pediatric intensive care unit. Transfusion (2006) 0.95

Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion (2009) 0.95

Diaphragm electrical activity during expiration in mechanically ventilated infants. Pediatr Res (2006) 0.95

Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol (2003) 0.95

Differences in organ dysfunctions between neonates and older children: a prospective, observational, multicenter study. Crit Care (2010) 0.94

Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am (2010) 0.94

Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood (2013) 0.93

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell Immunol (2012) 0.93

Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies. Crit Care (2012) 0.92

Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood (2003) 0.91

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study. Biol Blood Marrow Transplant (2011) 0.91

A new generation of N-aryl-N'-(1-alkyl-2-chloroethyl)ureas as microtubule disrupters: synthesis, antiproliferative activity, and beta-tubulin alkylation kinetics. J Med Chem (2003) 0.90

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials. Biol Blood Marrow Transplant (2008) 0.89

Risk factors associated with increased length of mechanical ventilation in children. Pediatr Crit Care Med (2012) 0.89

Canadian multicenter pilot trial of haploidentical donor transplantation. Blood Cells Mol Dis (2004) 0.89

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biol Blood Marrow Transplant (2002) 0.88

Controversies in the treatment of CML in children and adolescents: TKIs versus BMT? Biol Blood Marrow Transplant (2011) 0.88

Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Cancer Res (2004) 0.88

Complementary and contrasting roles of NK cells and T cells in pediatric umbilical cord blood transplantation. J Leukoc Biol (2011) 0.87

Developmental outcome after a single episode of status epilepticus. Epilepsy Behav (2011) 0.87